Katarzyna Muszyńska-Rosłan
Biographic Data
| ID | 8267663 |
|---|---|
| NAME | Katarzyna Muszyńska-Rosłan |
| GIVEN NAMES | Katarzyna |
| FAMILY NAME | Muszyńska-Rosłan |
| SIGNATURE | MUSZYŃSKA-ROSŁAN K |
| AFFILIATIONS | Medical University of Białystok |
| ORCID | 0000-0001-9551-2145 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results
Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). The standard first-line treatment for MS is intensive chemotherapy according to the AML protocol, regardless of bone marrow involvement. The role of allogeneic hematopoietic stem cell transplantation (alloHSCT) in the treatment of pediatric patients with …
No prominent works on this page.
The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results
Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). The standard first-line treatment for MS is intensive chemotherapy according to the AML protocol, regardless of bone marrow involvement. The role of allogeneic hematopoietic stem cell transplantation (alloHSCT) in the treatment of pediatric patients with …
Acute Myeloid Leukemia Research (1 work) · Chemotherapy (1 work) · Chronic Myeloid Leukemia Treatments (1 work) · Cohort (1 work) · Hematopoietic Stem Cell Transplantation (1 work) · Leukemia (1 work) · Myeloid (1 work) · Myeloid leukemia (1 work) · Myeloid sarcoma (1 work) · Retinoids in leukemia and cellular processes (1 work)